702
Views
3
CrossRef citations to date
0
Altmetric
State of the Art Reviews

Association of Megsin 2093C/T, 2180C/T and C25663G gene polymorphism with the risk of IgA nephropathy

, , &
Pages 817-822 | Received 14 Sep 2013, Accepted 26 Jan 2014, Published online: 27 Feb 2014

References

  • Narita I, Goto S, Saito N, et al. Genetic polymorphisms in the promoter and 5′ UTR region of the Fc alpha receptor (CD89) are not associated with a risk of IgA nephropathy. J Hum Genet. 2001;46:694–698
  • Bjorneklett R, Vikse BE, Bostad L, et al. Long-term risk of ESRD in IgAN; validation of Japanese prognostic model in a Norwegian cohort. Nephrol Dial Transplant. 2012;27:1485–1491
  • Maixnerova D, Merta M, Reiterova J, et al. The influence of two megsin polymorphisms on the progression of IgA nephropathy. Folia Biol (Praha). 2008;54:40–45
  • Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29:829–842
  • Kiryluk K, Li Y, Sanna-Cherchi S, et al. Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet. 2012;8:e1002765:1–16
  • Shinzawa M, Yamamoto R, Nagasawa Y, et al. Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathy. Clin Exp Nephrol. 2012;16:250–258
  • Szelestei T, Bähring S, Kovács T, et al. Association of a uteroglobin polymorphism with rate of progression in patients with IgA nephropathy. Am J Kidney Dis. 2000;36:468–473
  • Gettins PGW. Serpin structure, mechanism, and function. Chem Rev. 2002;102:4751–4804
  • Li YJ, Du Y, Li CX, et al. Family-based association study showing that immunoglobulin A nephropathy is associated with the polymorphisms 2093C and 2180T in the 3′ untranslated region of the megsin gene. J Am Soc Nephrol. 2004;15:1739–1743
  • Lim CS, Kim SM, Oh YK, et al. Megsin 2093T-2180C haplotype at the 3′ untranslated region is associated with poor renal survival in Korean IgA nephropathy patients. Clin Nephrol. 2008;70:101–109
  • Li L, Zhang TY, Cui LQ. Megsin gene C-25663G polymorphism and IgA nephropathy in Chinese Han population. China Foreign Med Treat. 2011;30:2–3
  • Xia YF, Huang S, Li CX, et al. A study of megsin gene C25663G polymorphism with IgA nephropathy. CJITWN. 2006;2:91–93
  • Joshi PH, Xu H, Lestrange R, et al. The M235T single nucleotide polymorphism in the angiotensinogen gene is associated with coronary artery calcium in patients with a family history of coronary artery disease. Atherosclerosis. 2013;226:433–439
  • Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169–180
  • Ding W, Wang F, Fang Q, et al. Association between two genetic polymorphisms of the renin-angiotensin-aldosterone system and diabetic nephropathy: a meta-analysis. Mol Biol Rep. 2012;39:1293–1303
  • Inagi R, Nangaku M, Miyata T, et al. Mesangial cell-predominant functional gene, megsin. Clin Exp Nephrol. 2003;7:87–92
  • Miyata T, Inagi R, Nangaku M, et al. Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion. J Clin Invest. 2002;109:585–593
  • Gytz Ammitzbøll C, Steffensen R, Jørgen Nielsen H, et al. Polymorphisms in the MASP1 gene are associated with serum levels of MASP-1, MASP-3, and MAp44. PLoS One. 2013;9:e73317:1–12
  • Inagi R, Yamamoto Y, Nangaku M, et al. A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice. Diabetes. 2006;55:356–366
  • Onogi H, Inagi R, Nangaku M, et al. Accelerated glomerular injury in hemi-nephrectomized transgenic mice of mesangial cell-predominant serpin, megsin. Nephron Exp Nephrol. 2004;96:e127–e133
  • Nangaku M, Miyata T, Suzuki D, et al. Cloning of rodent megsin revealed its up-regulation in mesangioproliferative nephritis. Kidney Int. 2001;60:641–652

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.